From: Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients
Variables | HF subjects (n=179) |
---|---|
Heart rate (bpm) | 76.2±13.6 |
QRS complex (ms) | 120 (98–160) |
QTc interval (ms) | 449.0 (414.0–478.5) |
PR interval (ms) | 172.9±29.2 |
Normal sinus ECG rhythm (%) | 68 |
6MWT (m) | 375 (250–450) |
MLHFQ | 38.6±24.1 |
LVEDD (mm) | 63.5±11.6 |
LVESD (mm) | 50.5±11.2 |
AI | 46.1±9.8 |
Left ventricular ejection fraction (%) | 32 (25–39) |
NT-proBNP (pmol/L) | 679.8 (405.5–1177.9) |
ACE inhibitor (%) | 65 |
β-blocker (%) | 61 |
Diuretic (%) | 78 |
Statin (%) | 37 |